Campbell & CO Investment Adviser LLC Invests $199,000 in Mallinckrodt PLC (MNK)

Campbell & CO Investment Adviser LLC acquired a new stake in Mallinckrodt PLC (NYSE:MNK) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,400 shares of the company’s stock, valued at approximately $199,000.

Several other institutional investors have also recently made changes to their positions in the company. Sheaff Brock Investment Advisors LLC lifted its holdings in shares of Mallinckrodt by 4.6% in the fourth quarter. Sheaff Brock Investment Advisors LLC now owns 13,440 shares of the company’s stock valued at $212,000 after buying an additional 594 shares during the period. Arizona State Retirement System lifted its holdings in shares of Mallinckrodt by 1.2% during the fourth quarter. Arizona State Retirement System now owns 59,797 shares of the company’s stock valued at $945,000 after purchasing an additional 714 shares during the last quarter. Comerica Bank lifted its holdings in shares of Mallinckrodt by 2.7% during the fourth quarter. Comerica Bank now owns 55,415 shares of the company’s stock valued at $1,178,000 after purchasing an additional 1,447 shares during the last quarter. FNY Investment Advisers LLC lifted its holdings in shares of Mallinckrodt by 210.4% during the fourth quarter. FNY Investment Advisers LLC now owns 2,288 shares of the company’s stock valued at $36,000 after purchasing an additional 1,551 shares during the last quarter. Finally, Greenleaf Trust lifted its holdings in shares of Mallinckrodt by 14.1% during the fourth quarter. Greenleaf Trust now owns 13,105 shares of the company’s stock valued at $207,000 after purchasing an additional 1,621 shares during the last quarter.

Several equities research analysts have recently commented on MNK shares. Zacks Investment Research raised Mallinckrodt from a “hold” rating to a “strong-buy” rating and set a $21.00 target price for the company in a report on Tuesday, January 8th. Mizuho reaffirmed a “hold” rating and set a $27.00 target price on shares of Mallinckrodt in a report on Tuesday, November 6th. Berenberg Bank set a $23.00 target price on Mallinckrodt and gave the company a “sell” rating in a report on Wednesday, November 7th. Wells Fargo & Co set a $27.00 target price on Mallinckrodt and gave the company a “hold” rating in a report on Friday, December 7th. Finally, Piper Jaffray Companies set a $39.00 target price on Mallinckrodt and gave the company a “buy” rating in a report on Friday, December 7th. Three analysts have rated the stock with a sell rating, nine have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. Mallinckrodt has a consensus rating of “Hold” and an average target price of $31.44.

Shares of NYSE MNK opened at $24.96 on Friday. The firm has a market cap of $2.04 billion, a PE ratio of 3.33, a P/E/G ratio of 0.24 and a beta of 2.33. The company has a debt-to-equity ratio of 0.93, a current ratio of 2.21 and a quick ratio of 2.05. Mallinckrodt PLC has a 12 month low of $11.65 and a 12 month high of $36.65.

Mallinckrodt (NYSE:MNK) last announced its quarterly earnings data on Tuesday, February 26th. The company reported $2.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.98 by $0.20. The firm had revenue of $834.90 million during the quarter, compared to the consensus estimate of $681.45 million. Mallinckrodt had a return on equity of 9.60% and a net margin of 65.24%. The business’s revenue for the quarter was up 5.4% on a year-over-year basis. During the same period in the prior year, the business earned $2.01 EPS. On average, research analysts anticipate that Mallinckrodt PLC will post 7.09 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Campbell & CO Investment Adviser LLC Invests $199,000 in Mallinckrodt PLC (MNK)” was first reported by Fairfield Current and is the property of of Fairfield Current. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://www.fairfieldcurrent.com/news/2019/03/01/campbell-co-investment-adviser-llc-invests-199000-in-mallinckrodt-plc-mnk.html.

Mallinckrodt Profile

Mallinckrodt public limited company develops, manufactures, markets, and distributes branded pharmaceutical products in Canada and the European Union, as well as in Latin American, the Middle Eastern, African, and the Asia-Pacific regions. The company markets branded pharmaceutical products for autoimmune and rare diseases in the specialty areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and gastrointestinal products.

Read More: Investing in Dividend Stocks

Want to see what other hedge funds are holding MNK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mallinckrodt PLC (NYSE:MNK).

Institutional Ownership by Quarter for Mallinckrodt (NYSE:MNK)



Leave a Reply